• LAST PRICE
    1.5800
  • TODAY'S CHANGE (%)
    Trending Up0.0200 (1.2821%)
  • Bid / Lots
    1.4700/ 1
  • Ask / Lots
    1.6900/ 1
  • Open / Previous Close
    1.5800 / 1.5600
  • Day Range
    Low 1.5800
    High 1.6300
  • 52 Week Range
    Low 1.1800
    High 2.6499
  • Volume
    60,774
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 1.56
TimeVolumeICAD
09:32 ET4871.58
09:39 ET15631.59
09:41 ET3201.5846
09:48 ET26361.59
10:03 ET1001.605
10:39 ET1001.61
11:04 ET5001.6
11:27 ET1001.61
11:44 ET1001.59
12:02 ET2001.61
12:16 ET1001.63
12:18 ET5001.62
12:20 ET2001.62
01:21 ET1001.62
01:28 ET1001.625
01:42 ET6031.62
01:55 ET30001.6103
01:57 ET1001.61
02:04 ET6201.61
02:13 ET7501.5932
02:27 ET9271.59
02:31 ET111271.59
02:38 ET1001.58
02:42 ET10001.5833
03:09 ET3001.5806
03:34 ET13101.585
03:38 ET7171.5832
03:39 ET62811.5899
03:52 ET1001.6
03:57 ET1001.6
03:59 ET124561.58
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesICAD
ICAD Inc
41.9M
-9.1x
---
United StatesEKSO
Ekso Bionics Holdings Inc
26.1M
-1.5x
---
United StatesMDAI
Spectral AI Inc
18.5M
-0.7x
---
United StatesRPID
Rapid Micro Biosystems Inc
37.7M
-0.8x
---
United StatesAXDX
Accelerate Diagnostics Inc
36.5M
-0.7x
---
United StatesPRPO
Precipio Inc
9.9M
-2.5x
---
As of 2024-09-22

Company Information

iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging and computed tomography. ProFound Suite offers 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation, all based on a 2D or 3D mammogram’s collection of images. ProFound Density Assessment standardizes and simplifies breast density reporting, algorithmically examining a woman’s breast anatomy from the mammogram image.

Contact Information

Headquarters
98 Spit Brook Rd Ste 100NASHUA, NH, United States 03062-5737
Phone
603-882-5200
Fax
603-880-3843

Executives

Executive Chairman of the Board, President, Chief Executive Officer
Dana Brown
Chief Financial Officer
Eric Lonnqvist
Chief Operating Officer
Michelle Strong
Chief Technology Officer
Jonathan Go
Chief Product Officer
Vasu Avadhanula

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$41.9M
Revenue (TTM)
$18.8M
Shares Outstanding
26.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.51
EPS
$-0.17
Book Value
$1.27
P/E Ratio
-9.1x
Price/Sales (TTM)
2.2
Price/Cash Flow (TTM)
---
Operating Margin
-28.33%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.